Search results
Replay wins IND clearance for PRAME T cell cancer therapy
Pharmaceutical Technology via Yahoo Finance· 1 day agoGenome writing company Replay Bio has had its investigational new drug (IND) application cleared by...
New technique improves T cell-based immunotherapies for solid tumors
Medical Xpress· 22 hours agoScientists from Scripps Research have enhanced an existing immunotherapy by removing the sugar coating surrounding solid tumors—such as in melanoma, breast, and prostate cancer—so T cells can ...
Revolutionizing Cancer Treatment: Key to Prolonging CAR T Cell Life Uncovered
SciTechDaily· 2 days agoFOXO1 is required for T cell memory and is linked to longer-lasting clinical outcomes in CAR T cell ...
Turning a tumor's 'shield' into a weapon against itself
Medical Xpress· 4 hours agoWang, the Chair of the Alfred E. Mann Department of Biomedical Engineering and the Dwight C. and...
Xyphos and Poseida to develop allogeneic cell therapies for cancer
Pharmaceutical Technology via Yahoo Finance· 7 hours agoPoseida focuses on progressing cell and gene therapies that have the potential to cure certain...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 10 hours agoPlanegg/Martinsried, May 2, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of
Do cutting-edge CAR-T-cell therapies cause cancer? What the data say
Nature· 3 days agoRegulators have identified around 30 cases of cancer linked to this blockbuster treatment. But is...
Biomarkers identified for successful treatment of bone marrow tumors
Medical Xpress· 6 days agoCAR T cell therapy has proven effective in treating various hematological cancers. In a clinical study, researchers from the University ...
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop...
FOX21 Colorado Springs· 16 hours agoPoseida is advancing differentiated cell and gene therapies with the capacity to cure certain cancers and rare diseases.
CD70 Antibodies CD70 Targeting Therapies Clinical Trials Market Opportunity Insight
Benzinga· 1 day agoDelhi, May 01, 2024 (GLOBE NEWSWIRE) -- Global CD70 Targeting Therapies Market Opportunity & Clinical Trials Insight 2024 Report Highlights: CD70 Targeting Therapies In Clinical Trials: > 20 TherapiesCD 70